Psychiatry News CME/CE

• First-Time Antipsychotic Use Linked to Rapid Weight Gain, Adverse Metabolic Changes in Kids CME/CE First-time, second-generation antipsychotic use in children and adolescents is associated with rapid and significant weight gain as well as varied adverse metabolic changes, new research shows.
  Medscape Medical News CME, November 2009
• Primary Care Clinicians Key in Preventing Major Depression in the Elderly CME/CE Factors routinely assessed in primary care identify elderly subjects who are candidates for depression prevention.
  Medscape Medical News CME, November 2009
• Depression in Older Cancer Patients Responds Better to Collaborative Program CME A collaborative program headed by a depression care manager, which included a structured psychotherapy program, was better than usual care in older cancer patients with depression.
  Medscape Medical News CME, November 2009
• More Suicidal Ideation With Nortriptyline vs Escitalopram Among Men, but Both Drugs Decrease Adverse Effect CME Men treated for depression with nortriptyline had almost a 10-fold increase in suicidal thoughts at 5 weeks vs men treated with escitalopram, but both drugs effectively reduced suicidal ideation.
  Medscape Medical News CME, November 2009
• Psychiatric Disorders, Sexual Trauma Linked to Urinary Tract Symptoms CME Depression, anxiety, and sexual trauma have all been implicated as risk factors in lower urinary tract symptoms.
  Medscape Medical News CME, October 2009
• FDA Safety Changes: Ultram, Ultracet, Sustiva, Kayexalate CME/CE The FDA has approved safety labeling revisions for tramadol HCl tablets, tramadol plus acetaminophen tablets, efavirenz capsules and tablets, and sodium polystyrene sulfonate powder.
  Medscape Medical News CME, October 2009
• Omega-3s No Help to SSRI-Treated CHD Patients CME The researchers say more study is still needed, as it is unclear whether higher doses of omega-3 fatty acids or sertraline, longer treatment, or a different ratio of EPA to DHA would be favorable.
  Heartwire CME, October 2009
• Declining Visuospatial Skills May Precede Eventual Alzheimer's Disease Diagnosis CME A new longitudinal study shows that a decline in cognitive abilities, especially in visuospatial skills, may lead to earlier identification of patients at risk of developing Alzheimer's disease.
  Medscape Medical News CME, October 2009
• Maternal Smoking in Pregnancy Linked to Increased Risk for Psychotic Symptoms in Adolescents CME/CE A new cohort study from the United Kingdom shows that maternal (but not paternal) use of tobacco during pregnancy is associated with an increased risk for psychotic symptoms in their children.
  Medscape Medical News CME, October 2009
• Small but Significant Risk for Heart Defects Linked to SSRI Use During Pregnancy CME A link may exist between SSRI use in early pregnancy and a small risk for heart defects, but experts say clinicians must weigh this against risks associated with untreated or undertreated depression.
  Medscape Medical News CME, October 2009
• FDA Safety Changes: Symbyax, Zoladex, INOmax CME/CE The FDA has approved safety labeling revisions for olanzapine/fluoxetine HCl capsules (Symbyax), goserelin acetate implants (Zoladex), and nitric oxide for inhalation (INOmax).
  Medscape Medical News CME, October 2009
• Prenatal SSRIs Linked to Problems in Newborns CME/CE Babies of mothers who took selective serotonin reuptake inhibitors during pregnancy are more likely to have preterm birth, low 5-minute Apgar scores, and neonatal intensive care unit admission.
  Medscape Medical News CME, October 2009
• Mediterranean Diet May Cut Depression Risk CME/CE A diet rich in vegetables, fruits, nuts, whole grains, and fish and light on red meat may prevent depression.
  Medscape Medical News CME, October 2009
• Multiple Strokes, Not Vascular Risk, Most Predictive of Poststroke Dementia CME Poststroke dementia, occurring in 10% of stroke patients and more than 30% of those with multiple strokes, may be prevented with optimal poststroke care.
  Medscape Medical News CME, October 2009
• European Guidelines Update Drug Treatment of Migraine CME/CE Oral nonsteroidal anti-inflammatory drugs and triptans, preceded by antiemetics, are now advised for the acute treatment of migraine under updated treatment guidelines.
  Reuters Health Information CME, October 2009
• FDA Safety Changes: Zyprexa, Geodon, Lariam, Merrem IV, Primaxin CME/CE The FDA has approved safety labeling revisions for olanzapine, ziprasidone, mefloquine HCl tablets, meropenem, and imipenem/cilastatin.
  Medscape Medical News CME, September 2009
• Depression, Anxiety Symptoms Common in Preschoolers CME Symptoms of depression and anxiety are common in very young children. Risk factors for these symptoms include difficult temperament at 5 months and maternal history of depression.
  Medscape Medical News CME, September 2009
• Difficulties With Activities of Daily Living Strong Predictor of Progression to Dementia CME/CE Difficulty with activities of daily living in individuals with mild cognitive impairment is a strong predictor of progression to dementia, new research suggests.
  Medscape Medical News CME, September 2009
• Bullying May Affect Girls More Than Boys CME/CE Bullying predicts future psychiatric problems for all girls but for only those boys who already have psychopathology.
  Medscape Medical News CME, September 2009
• Unresolved Depression Doubles Risk for Mortality in Post-MI Patients CME The latest findings from the SADHART study show that new-onset depression is just as deadly as recurrent depression in patients who have had a myocardial infarction.
  Medscape Medical News CME, September 2009